Keywords: smc, clears, symbicort, smart, asthma, anglo-swedish, drug
SMC clears Symbicort SMART for asthma
Article | 18 June 2007
Anglo-Swedish drug major AstraZeneca says that its asthma treatment Symbicort SMART (budesonide/formoterol) has been approved by the agency that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
